Merck completed the acquisition of Intermolecular for $62m.

Merck, a science and technology company, completed the acquisition of Intermolecular, a trusted partner for advanced materials innovation, for $1.20 per share in an all-cash transaction, representing an equity value of Intermolecular of c. $62m. “Today is a very special day for us as we successfully complete the acquisition and welcome Intermolecular to Merck. For three and a half centuries, we have been dedicated to advancing science and technology for the benefit of human progress. I am glad that Intermolecular shares this spirit. Together we are well-positioned to drive and accelerate future innovations in the electronic materials industry,” Kai Beckmann, Merck Member of the Executive Board and Performance Materials CEO.